USPTO serial 77797670
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Indianapolis, IN
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Acquisition and merger consultation; Assistance, advisory services and consultancy with regard to business planning, business analysis, business management, and business organization; Business acquisition and merger consultation; Business acquisitions consultation; Business advisory services, consultancy and information; Business consultation; Business consultation services; Business consultation services in the fields of supply chain analysis, regulation compliance and counterfeit detection; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting services in the field of organizational change management; Business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; Business consulting services relating to the integration of the areas of business process technology, organizational learning, change management, and operational sustainability; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business consulting, management, planning and supervision; Business management and consultation; Business management and consulting services for the health care industry, namely, providing industry expertise and supplier partnerships; Business management consultancy and advisory services; Business management consultancy as well as development of processes for the analysis and the implementation of strategy plans and management projects; Business management consultancy in the field of insourcing, namely, assisting businesses in the development of processes for the analysis and the implementation of the delegation of operations or jobs from production within a business to an internal entity that specializes in that operation; Business management consultation; Business management consultation and services, namely, managing and administering non-core functions, namely, mailing and shipping, records management, information services, administration, payroll and accounting, and telemarketing services; Business management consulting; Business management consulting and advisory services; Business management consulting in the field of team development; Business management consulting with relation to strategy, financing, marketing, production, personnel and sale matters for companies involved with thin film and nano technologies and plasma processes; Business merger consultation; Business organisation and management consulting services; Business organisation consulting; Business organization and management consulting; Business organization and operation consultancy; Business organization consulting; Business organizational consultation; Business relocation consulting; Business research consultation; Business risk management consultation; Business services, namely, consulting in the field of supply chain verification for the presence of genetically modified organisms; Consultancy and advisory services in the field of business strategy; Consultancy of personnel recruitment; Consultancy services regarding business strategies; Consultation in the field of business acquisitions; Consultation services in the field of company, business sector and industry data and research; Consulting in the fields of business organization and management; Consulting services in the area of sustainable business solutions; Consulting services in the field of medical product approval for commercial purposes; Disaster recovery services, namely, business planning and business continuity consulting; Employment recruiting consultation; Industrial management consultation including cost/yield analyses; Interactive record-keeping services for use in risk management and regulatory compliance by insurers and professionals in the medical field; Management and business consulting services in the field of training and recruitment; New business venture development and formation consulting services; Personnel consultancy; Personnel management consultation; Professional business consultation; Professional business consulting; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Providing business management information in connection with consulting and advisory services in the field of strategic planning; Providing organizational development consulting services; Providing technical consulting services and information management services, namely, clinical data and regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval | ACTIVE | Jun 30, 2009 |
| 042 | Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the field of computer-based information systems for businesses; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics | ACTIVE | Jun 30, 2009 |
| 044 | Medical and pharmaceutical consultation; Medical consultations | ACTIVE | Jun 30, 2009 |
| 045 | Consulting services in the field of listing and tracking of foreign and domestic government regulatory requirements, for obtaining permits and regulatory compliance | ACTIVE | Jun 30, 2009 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 17, 2010 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 17, 2010 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 19, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2009 | NWAP | NEW APPLICATION ENTERED | — |